Compositions and methods for rapid and reversible biomolecular labeling
US-2024426816-A1 · Dec 26, 2024 · US
US11760792B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11760792-B2 |
| Application number | US-201816755373-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 15, 2018 |
| Priority date | Oct 13, 2017 |
| Publication date | Sep 19, 2023 |
| Grant date | Sep 19, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a GRP78-derived peptide for screening highly efficient stem cells and the use thereof, and more particularly, to screening highly efficient stem cells using, as a marker, a GRP78-derived peptide capable of binding to the binding domain of GRP78 protein on the cell surface. According to the present invention, the GRP78-derived peptide comprising only a specific amino acid sequence capable of recognizing highly efficient stem cells, among the amino acid sequence of GRP78, makes it possible to screen only non-senescent young stem cells. In addition, when stem cells are treated with the GRP78-derived peptide or the GRP78-derived peptide is introduced into stem cells, the efficiency of the stem cells can be increased. Thus, the GRP78-derived peptide is useful for the production of stem cell therapy products having excellent efficacy.
Opening claim text (preview).
The invention claimed is: 1. A peptide consisting of the amino acid sequence of SEQ ID NO: 14. 2. The peptide of claim 1 , wherein the peptide is derived from Glucose-regulated protein 78 (GRP78). 3. The peptide of claim 1 , wherein the peptide of SEQ ID NO: 14 binds ATP, which is regulated by GRP78. 4. A method of screening highly efficient stem cells that express GRP78, comprising steps of: (a) conjugating a fluorescent label to a peptide that binds GRP78 and consists of the amino acid sequence of SEQ ID NO: 14; (b) culturing the fluorescent labeled-conjugated peptide with stem cells to allow binding of the fluorescent labeled-conjugated peptide with stem cells that express GRP78; and (c) screening for GRP78-expressing stem cells under a fluorescence microscope. 5. A composition comprising the peptide of claim 1 . 6. A kit comprising the peptide of claim 1 . 7. A method of increasing efficiency of stem cells that express GRP78 comprising treating stem cells that express GRP78 with the peptide of claim 1 .
Animal cells · CPC title
against material from animals or humans · CPC title
Stem cells · CPC title
involving proteins, peptides or amino acids {(involving lipoproteins G01N33/92)} · CPC title
Chemical aspects of mass spectrometric analysis of biological material · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.